Baxter International Stock Plummets -21% With 5-Day Losing Streak
Baxter International (BAX) stock hit day 5 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -21% return. The company has lost about $2.5 Bil in value over the last 5 days, with its current market capitalization at about $9.3 Bil. The stock remains 36.5% below its value at the end of 2024. This compares with year-to-date returns of 16.5% for the S&P 500.
BAX provides a global portfolio of healthcare products, distributing through direct sales, independent distributors, drug wholesalers, and specialty pharmacies across approximately 100 countries. Is this drop a warning sign or a setup for rebound? Deep dive with Buy or Sell BAX.
A single stock can be risky, but there is a huge value to a broader, diversified approach we take with the Trefis High Quality Portfolio. We go beyond just equities. Is a portfolio of 10% commodities, 10% gold, and 2% crypto in addition to equities and bonds likely to return more during the next 1-3 years, and protect you better if markets crash 20%? We have crunched the numbers.
Comparing BAX Stock Returns With The S&P 500
The following table summarizes the return for BAX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | BAX | S&P 500 |
|---|---|---|
| 1D | -1.4% | 0.2% |
| 5D (Current Streak) | -21.4% | -0.3% |
| 1M (21D) | -23.7% | 2.0% |
| 3M (63D) | -19.7% | 8.8% |
| YTD 2025 | -36.5% | 16.5% |
| 2024 | -22.4% | 23.3% |
| 2023 | -21.9% | 24.2% |
| 2022 | -39.6% | -19.4% |
What is the point? Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact. Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: BAX Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 46 S&P constituents with 3 days or more of consecutive gains and 80 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 38 | 20 |
| 4D | 5 | 8 |
| 5D | 1 | 32 |
| 6D | 1 | 7 |
| 7D or more | 1 | 13 |
| Total >=3 D | 46 | 80 |
Key Financials for Baxter International (BAX)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $10.4 Bil | $10.6 Bil |
| Operating Income | $707.0 Mil | $439.0 Mil |
| Net Income | $2.7 Bil | $-649.0 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $2.6 Bil | $2.8 Bil |
| Operating Income | $58.0 Mil | $191.0 Mil |
| Net Income | $126.0 Mil | $91.0 Mil |
The losing streak BAX stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.